1aqd: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
New page: left|200px<br /> <applet load="1aqd" size="450" color="white" frame="true" align="right" spinBox="true" caption="1aqd, resolution 2.45Å" /> '''HLA-DR1 (DRA, DRB1 ...
 
No edit summary
Line 1: Line 1:
[[Image:1aqd.gif|left|200px]]<br />
[[Image:1aqd.gif|left|200px]]<br /><applet load="1aqd" size="350" color="white" frame="true" align="right" spinBox="true"  
<applet load="1aqd" size="450" color="white" frame="true" align="right" spinBox="true"  
caption="1aqd, resolution 2.45&Aring;" />
caption="1aqd, resolution 2.45&Aring;" />
'''HLA-DR1 (DRA, DRB1 0101) HUMAN CLASS II HISTOCOMPATIBILITY PROTEIN (EXTRACELLULAR DOMAIN) COMPLEXED WITH ENDOGENOUS PEPTIDE'''<br />
'''HLA-DR1 (DRA, DRB1 0101) HUMAN CLASS II HISTOCOMPATIBILITY PROTEIN (EXTRACELLULAR DOMAIN) COMPLEXED WITH ENDOGENOUS PEPTIDE'''<br />


==Overview==
==Overview==
BACKGROUND: Class II major histocompatibility complex (MHC) proteins are, cell surface glycoproteins that bind peptides and present them to T cells, as part of the mechanism for detecting and responding to foreign material, in the body. The peptide-binding activity exhibits allele-specific, preferences for particular sidechains at some positions, although the, structural basis of these preferences is not understood in detail. We have, determined the 2.45 A crystal structure of the human class II MHC protein, HLA-DR1 in complex with the tight binding endogenous peptide A2 (103-117), in order to discover peptide-MHC interactions that are important in, determining the binding motif and to investigate conformational, constraints on the bound peptide. RESULTS: The bound peptide adopts a, polyproline II-like conformation and places several sidechains within, pockets in the binding site. Bound water molecules mediate MHC-peptide, contacts at several sites. A tryptophan residue from the beta 2 'lower', domain of HLA-DR1 was found to project into a pocket underneath the, peptide-binding domain and may be important in modulating interdomain, interactions in MHC proteins. CONCLUSIONS: The peptide-binding motif of, HLA-DR1 includes an aromatic residue at position +1, an arginine residue, at position +2, and a small residue at position +6 (where the numbering, refers to the normal MHC class II convention); these preferences can be, understood in light of interactions observed in the peptide-MHC complex., Comparison of the structure with that of another MHC-peptide complex shows, that completely different peptide sequences bind in essentially the same, conformation and are accommodated with only minimal rearrangement of, HLA-DR1 residues. Small conformational differences that are observed, appear to be important in interactions with other proteins.
BACKGROUND: Class II major histocompatibility complex (MHC) proteins are cell surface glycoproteins that bind peptides and present them to T cells as part of the mechanism for detecting and responding to foreign material in the body. The peptide-binding activity exhibits allele-specific preferences for particular sidechains at some positions, although the structural basis of these preferences is not understood in detail. We have determined the 2.45 A crystal structure of the human class II MHC protein HLA-DR1 in complex with the tight binding endogenous peptide A2 (103-117) in order to discover peptide-MHC interactions that are important in determining the binding motif and to investigate conformational constraints on the bound peptide. RESULTS: The bound peptide adopts a polyproline II-like conformation and places several sidechains within pockets in the binding site. Bound water molecules mediate MHC-peptide contacts at several sites. A tryptophan residue from the beta 2 'lower' domain of HLA-DR1 was found to project into a pocket underneath the peptide-binding domain and may be important in modulating interdomain interactions in MHC proteins. CONCLUSIONS: The peptide-binding motif of HLA-DR1 includes an aromatic residue at position +1, an arginine residue at position +2, and a small residue at position +6 (where the numbering refers to the normal MHC class II convention); these preferences can be understood in light of interactions observed in the peptide-MHC complex. Comparison of the structure with that of another MHC-peptide complex shows that completely different peptide sequences bind in essentially the same conformation and are accommodated with only minimal rearrangement of HLA-DR1 residues. Small conformational differences that are observed appear to be important in interactions with other proteins.


==Disease==
==Disease==
Line 11: Line 10:


==About this Structure==
==About this Structure==
1AQD is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1AQD OCA].  
1AQD is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1AQD OCA].  


==Reference==
==Reference==
Line 17: Line 16:
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Protein complex]]
[[Category: Protein complex]]
[[Category: Murthy, V.L.]]
[[Category: Murthy, V L.]]
[[Category: Stern, L.J.]]
[[Category: Stern, L J.]]
[[Category: complex (mhc protein/antigen)]]
[[Category: complex (mhc protein/antigen)]]
[[Category: histocompatibility antigen]]
[[Category: histocompatibility antigen]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 16:01:11 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 11:47:11 2008''

Revision as of 12:47, 21 February 2008

File:1aqd.gif


1aqd, resolution 2.45Å

Drag the structure with the mouse to rotate

HLA-DR1 (DRA, DRB1 0101) HUMAN CLASS II HISTOCOMPATIBILITY PROTEIN (EXTRACELLULAR DOMAIN) COMPLEXED WITH ENDOGENOUS PEPTIDE

OverviewOverview

BACKGROUND: Class II major histocompatibility complex (MHC) proteins are cell surface glycoproteins that bind peptides and present them to T cells as part of the mechanism for detecting and responding to foreign material in the body. The peptide-binding activity exhibits allele-specific preferences for particular sidechains at some positions, although the structural basis of these preferences is not understood in detail. We have determined the 2.45 A crystal structure of the human class II MHC protein HLA-DR1 in complex with the tight binding endogenous peptide A2 (103-117) in order to discover peptide-MHC interactions that are important in determining the binding motif and to investigate conformational constraints on the bound peptide. RESULTS: The bound peptide adopts a polyproline II-like conformation and places several sidechains within pockets in the binding site. Bound water molecules mediate MHC-peptide contacts at several sites. A tryptophan residue from the beta 2 'lower' domain of HLA-DR1 was found to project into a pocket underneath the peptide-binding domain and may be important in modulating interdomain interactions in MHC proteins. CONCLUSIONS: The peptide-binding motif of HLA-DR1 includes an aromatic residue at position +1, an arginine residue at position +2, and a small residue at position +6 (where the numbering refers to the normal MHC class II convention); these preferences can be understood in light of interactions observed in the peptide-MHC complex. Comparison of the structure with that of another MHC-peptide complex shows that completely different peptide sequences bind in essentially the same conformation and are accommodated with only minimal rearrangement of HLA-DR1 residues. Small conformational differences that are observed appear to be important in interactions with other proteins.

DiseaseDisease

Known diseases associated with this structure: Abacavir hypersensitivity, susceptibility to OMIM:[142800], Ankylosing spondylitis, susceptibility to, 1 OMIM:[142800], Stevens-Johnson syndrome, susceptibility to OMIM:[142800]

About this StructureAbout this Structure

1AQD is a Protein complex structure of sequences from Homo sapiens. Full crystallographic information is available from OCA.

ReferenceReference

The class II MHC protein HLA-DR1 in complex with an endogenous peptide: implications for the structural basis of the specificity of peptide binding., Murthy VL, Stern LJ, Structure. 1997 Oct 15;5(10):1385-96. PMID:9351812

Page seeded by OCA on Thu Feb 21 11:47:11 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA